Tekla Healthcare Investors (HQH) stock: key figures, P/E, revenue and dividend

Financials · Asset Management & Custody Banks · United States · ISIN US87911J1034

Price
21.42 USD
Market cap
1.15 bn USD
P/E (2025)
11.65
P/S (2025)
11.51
Dividend yield
11.53 %
Net margin
98.80 %
Return on equity (ROE)
9.02 %
Return on assets (ROA)
8.99 %

Tekla Healthcare Investors financials

Fiscal year20242025
Revenue10.77 m USD99.81 m USD
Gross profit10.77 m USD99.81 m USD
Operating income-220,271.00 USD98.61 m USD
Net income184.95 m USD98.61 m USD
Diluted EPS – continuing operations3.55 USD1.84 USD

Full history since 1996, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Tekla Healthcare Investors

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.